Skip to main content
Rheumatology
FULL MENU
Close Menu
Rheumatology
Diseases & Conditions
Ankylosing Spondylitis
Gout
Lupus & CTDs
Orthopedics
Osteoarthritis
Osteoporosis
Pain
Psoriatic Arthritis
Rheumatoid Arthritis
Spondyloarthritis
MD-IQ
RA
Business of Medicine
Coronavirus Updates
Conference Coverage
Guselkumab achieves highest-ever response rates in psoriasis
Publish date:
October 12, 2016
bjancin@frontlinemedcom.com
Pages
« first
1
2
Next Article:
Birth outcomes unaffected by paternal immunosuppressive therapy
Psoriatic Arthritis
Close
MDedge Home
Diseases & Conditions
Ankylosing Spondylitis
Gout
Long COVID
Lupus & CTDs
Orthopedics
Osteoarthritis
Osteoporosis
Pain
Psoriatic Arthritis
Rheumatoid Arthritis
Spondyloarthritis
Subspecialties
Pediatrics
Business of Medicine
Diversity in Medicine
Explore
20th Anniversary
Challenge Center
Explore
Psoriatic Arthritis Challenge Center
CME
Condition Center
Explore
Psoriatic Arthritis Resource Center
Conference ReCAP
For Residents
Latest News
Explore
Conference Coverage
Feature
From the Journals
Guidelines
Medicine’s Lighter Side
News From the FDA/CDC
News by Conference
Multimedia
Explore
Audio
Explore
All MDedge Podcasts
Video
Perspectives
Explore
Commentary
Law & Medicine
Rheum for Action
The Office
Quizzes & Polls
Explore
MD-IQ
ReCAP
Research Summaries
Explore
Clinical Edge Journal Scan
Roundtables
Sponsored Content
Explore
A Shifting Understanding of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Subscribe to Rheumatology News
Supplements
Medical Directors / Pharmacy Directors
Nurse Practitioners / Physician Assistants
Residents
VA / DoD / PHS
More
MDedge